Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...

Researchers compared the safety and efficacy profiles of oral P2Y12 inhibitors among patients receiving percutaneous coronary intervention.

Background Postoperative atrial fibrillation (AF) is a common complication after coronary artery bypass grafting (CABG) but is less well characterised after multivessel percutaneous coronary ...

Previous studies suggest that the proportion of ischemic risk zone that becomes necrotic following myocardial infarction (MI) is directly correlated with temperature. According to Hale and Kloner, [1] ...

Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown. The incidence of ...

Primary percutaneous coronary intervention, where available, has become the therapy of choice in myocardial reperfusion during ST-elevation myocardial infarction. However, in a significant proportion ...

Percutaneous coronary intervention (PCI) is the cornerstone of reperfusion therapy in myocardial infarction, aiming to promptly restore epicardial blood flow and preserve viable myocardium. Strategies ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Interventional cardiology made its debut 27 years ago, when Andreas Grüntzig performed the first percutaneous transluminal coronary angioplasty in a human. Since then, rapid expansion of our knowledge ...

Percutaneous coronary intervention (PCI) is a procedure that opens blocked arteries and restores blood flow to the heart. Timely access to hospitals offering PCI services can be a matter of life or ...